RA

Ravi Ashokkumar Agrawal

Active Director Designated Partner DIN 01579449
DIN 01579449 First appointment Aug 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 6 historical roles
Total affiliations 7 Since Aug 2004
Shareholding value •••• Premium profile

About Ravi Ashokkumar Agrawal

Data last updated:

Ravi Ashokkumar Agrawal is a Designated Partner at Cubit Lifesciences Llp (since 2023). The companies operate in Pharma, Media and Publishing and Metals and Minerals. Cubit Lifesciences Llp reported revenue of ₹76.66 Cr (FY 2023). Earlier, Ravi Ashokkumar Agrawal was a Director at Acacia Biotech Limited (2005–2019) and Director at Radius Impex Private Limited (2008–2009) and 4 more.

DIN 01579449
Primary Designation Designated Partner
Industry Pharma
First Appointment 24 Aug 2004
Oldest Company Age 15 yrs
Largest company Cubit Lifesciences Llp · ₹76.66 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Aug 20232018₹76.66 Cr (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acacia Biotech Limited U24230GJ2005PLC046251
Director05 Jul 20052005₹79.2 Lakh (FY 2025)Active
Radius Impex Private Limited U85190MH2008PTC185154
Director28 Jul 20082008₹80,240 (FY 2023)Active
Mahavir Rolling Mill Private Limited U28100GJ2004PTC044637
Director24 Aug 20042004Converted To Llp
Partner13 Aug 20212021Strike Off
Future Lifesciences Private Limited U24230GJ2011PTC064278
Director05 Mar 20112011Strike Off
Salubris Biopharm Private Limited U24230GJ2011PTC067757
Whole-Time Director09 Nov 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ravi Ashokkumar Agrawal

NameDINCompanyDesignation
Ashok Kumar Agrawal08154630Cubit Lifesciences LlpDesignated Partner
Prabhat Agrawal08154635Cubit Lifesciences LlpDesignated Partner
Priyanka Prabhat Agrawal03498192Cubit Lifesciences LlpDesignated Partner
Shalini Ravi Agrawal08249108Cubit Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cusan Wellness Llp
Future Lifesciences Private Limited
Salubris Biopharm Private Limited
Cubit Lifesciences Llp
Premium access

Shareholding and investment profile for Ravi Ashokkumar Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Ashokkumar Agrawal

Ravi Ashokkumar Agrawal currently holds 1 directorship: Cubit Lifesciences Llp (Designated Partner, since 24 Aug 2023, revenue ₹76.66 Cr (FY 2023)).

Ravi Ashokkumar Agrawal was first appointed on 24 Aug 2004 as Director at Mahavir Rolling Mill Private Limited. The most recent appointment on record is 24 Aug 2023 at Cubit Lifesciences Llp.

Ravi Ashokkumar Agrawal held 6 earlier board appointments: Acacia Biotech Limited (Director, 05 Jul 2005 to 13 Jun 2019); Radius Impex Private Limited (Director, 28 Jul 2008 to 03 Feb 2009); Mahavir Rolling Mill Private Limited (Director, 24 Aug 2004 to 12 Apr 2019); Cusan Wellness Llp (Partner, from 13 Aug 2021); Future Lifesciences Private Limited (Director, from 05 Mar 2011); and 1 more.

The current boards of Ravi Ashokkumar Agrawal's companies include Ashok Kumar Agrawal (Cubit Lifesciences Llp), Prabhat Agrawal (Cubit Lifesciences Llp), Priyanka Prabhat Agrawal (Cubit Lifesciences Llp), Shalini Ravi Agrawal (Cubit Lifesciences Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available